Finch Research and Development LLC.
4 clinical trials · Sponsor
◉ Watch Finch Research and Development LLC.
| Record | Firm | Date |
|---|---|---|
| A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (NCT05153499) | Finch Research and Development LLC. | 2021-11-15 |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) (NCT03829878) | Finch Research and Development LLC. | 2020-05-01 |
| Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (NCT03497806) | Finch Research and Development LLC. | 2018-05-01 |
Track Finch Research and Development LLC. automatically
Every clearance here is in the API, with alerts when new ones post.